A fungal eye infection occurs when fungi invade the cornea or internal structures of the eye, causing pain, redness, blurred vision, and, if untreated, permanent vision loss. The most common form is fungal keratitis, an infection of the cornea that accounts for the majority of microbial keratitis cases in tropical and lower-income countries, where filamentous fungi like Fusarium and Aspergillus are the leading culprits.1PubMed Central. Mycotic Keratitis-A Global Threat from the Filamentous Fungi In temperate climates, contact lens wear is the bigger risk factor, and fungi like Candida play a larger role. What makes these infections particularly frustrating for patients and doctors alike is that they are harder to diagnose, slower to respond to treatment, and costlier to manage than their bacterial counterparts.
Who Is Most at Risk
Two populations face the highest risk, and their paths to infection look very different. The first is agricultural workers. Fungal corneal ulcers most commonly follow a scratch or puncture from plant material, such as a thorn, leaf, or grain husk, that introduces fungal spores directly into the cornea.2PubMed Central. Keratomycosis after incidental spillage of vegetative material into the eye: Report of two cases In parts of South Asia, sub-Saharan Africa, and Latin America, this is so common among farmers and harvesters that fungal keratitis is effectively an occupational disease. Even incidental contact with vegetative debris can be enough to start an infection in an otherwise healthy eye.
The second high-risk group is contact lens wearers. In wealthier countries with less agricultural exposure, contact lenses are the primary route. Fungi can form biofilms on soft lenses, creating a protected colony that is difficult to dislodge or kill. Studies have shown that clinical isolates of both Fusarium and Candida form biofilms on all types of soft contact lenses tested, with the structure of those biofilms varying depending on the lens material.3PubMed Central. Fusarium and Candida albicans biofilms on soft contact lenses: model development, influence of lens type, and susceptibility to lens care solutions Common keratitis-associated fungi, including Aspergillus fumigatus and Fusarium solani, have all demonstrated the ability to colonize lenses in this way.4PubMed. Effects of lactoferricin B against keratitis-associated fungal biofilms
Other factors that increase susceptibility include using topical corticosteroids (which suppress the eye’s local immune defenses), prior eye surgery, chronic dry eye, and any condition that weakens the immune system. But for most people who develop fungal keratitis, the story starts with either a plant scratch or a contaminated contact lens.
The Contact Lens Solution Outbreak
The connection between contact lens care products and fungal eye infection became impossible to ignore during 2005 and 2006, when an unprecedented global outbreak of Fusarium keratitis struck. More than 250 cases were reported worldwide, primarily linked to Bausch & Lomb’s ReNu with MoistureLoc multipurpose contact lens disinfecting solution.5PubMed Central. In the aftermath of the Fusarium keratitis outbreak: What have we learned? In Hong Kong alone, a case-control study found that using that specific solution was the single strongest predictor of developing the infection, with an adjusted odds ratio above 26 compared to non-users.6PubMed. A multi-country outbreak of fungal keratitis associated with a brand of contact lens solution: the Hong Kong experience
Later investigation revealed a specific mechanism behind the failure. The antimicrobial ingredient in the solution, alexidine, lost its ability to kill fungi and bacteria when heated inside the product’s plastic containers. Incubation at elevated temperatures in the original high-density polyethylene bottles caused a dramatic, statistically significant loss of antimicrobial capability against all fungi tested, all gram-positive bacteria, and certain gram-negative species. The same loss did not occur when the solution was heated in glass containers, pointing to an interaction between the plastic and the disinfectant rather than a flaw in the chemical itself.7PubMed. Pan-antimicrobial failure of alexidine as a contact lens disinfectant when heated in Bausch & Lomb plastic containers: implications for the worldwide Fusarium keratitis epidemic of 2004 to 2006 The product was eventually recalled, but the outbreak drove lasting changes in how contact lens solutions are tested for antifungal performance.
What a Fungal Eye Infection Looks and Feels Like
Symptoms typically include eye pain, redness, tearing, light sensitivity, blurred vision, and a sensation that something is stuck in the eye. A whitish infiltrate on the cornea is usually visible, sometimes with a yellowish discharge. These symptoms overlap heavily with bacterial keratitis, which is exactly the problem: distinguishing one from the other based on appearance alone is unreliable.
In a photographic survey, trained clinicians correctly identified whether a corneal infection was bacterial or fungal only about two-thirds of the time.8PubMed Central. The Clinical Differentiation of Bacterial and Fungal Keratitis: A Photographic Survey Certain features do tip the odds toward a fungal diagnosis. Satellite lesions, small infiltrate spots scattered around the main ulcer, were roughly six times more likely in fungal cases. An endothelial plaque (a deposit on the inner surface of the cornea) was about eight times more common. Feathery, irregular edges to the ulcer and deeper stromal involvement also pointed toward fungi, while signs like stromal melting and a ground-glass appearance were more characteristic of bacterial infection.9PLOS ONE. Predicting factors and prediction model for discriminating between fungal infection and bacterial infection in severe microbial keratitis
The practical implication: if you develop a painful red eye with vision changes, especially after an eye injury or while wearing contact lenses, you need to see an ophthalmologist rather than guessing at the cause. Reaching for leftover antibiotic drops from a previous infection is a common mistake. Antibacterial drops will not touch a fungal infection, and the delay in proper treatment can cost you vision.
Why Diagnosis Takes Longer Than You Would Expect
The standard approach starts with scraping a small sample from the corneal ulcer and looking at it under a microscope, often using a potassium hydroxide (KOH) preparation that dissolves human cells and makes fungal elements easier to spot. The sensitivity of this test varies a great deal depending on technique. One study using a modified staining method reported sensitivity as high as roughly 88%, while standard KOH preparations have been reported with sensitivity as low as 33% in other settings.10PubMed Central. Efficacy and Rapidity of Potassium Hydroxide Mount and Modified Chicago Sky Blue 6B Stain with Potassium Hydroxide in Fungal Keratitis Detection11Bangladesh Journal of Medical Science. Potassium Hydroxide (KOH) Wet Preparation for the Laboratory Diagnosis of Suppurative Corneal Ulcer That range means a negative KOH test does not rule out fungal keratitis.
Fungal culture remains the gold standard for definitive identification, but fungi grow slowly. Results can take days to weeks, and the sensitivity of culture itself is far from perfect. One study of cases diagnosed by combined lab and clinical criteria found that fungal culture detected only about 44% of confirmed cases.12PubMed Central. Efficacy and Rapidity of Potassium Hydroxide Mount and Modified Chicago Sky Blue 6B Stain with Potassium Hydroxide in Fungal Keratitis Detection This means doctors often have to start treatment based on clinical suspicion and microscopy results, adjusting once culture data come back.
Newer tools are filling some of these gaps. In vivo confocal microscopy allows clinicians to visualize fungal structures directly within the cornea without scraping, offering a non-invasive way to see hyphae and pseudofilaments in real time.13PubMed Central. In vivo confocal microscopy in fungal keratitis14PubMed. The use of in vivo confocal microscopy in fungal keratitis – Progress and challenges Meanwhile, molecular techniques like PCR can detect fungal DNA at extremely low concentrations, down to fewer than ten organisms per sample in some protocols.15PubMed. Detection and identification of fungal pathogens by PCR and by ITS2 and 5.8S ribosomal DNA typing in ocular infections For deeper infections like fungal endophthalmitis (where the infection reaches the inside of the eye), broad-range real-time PCR testing of fluid samples has been used to detect fungal DNA in cases where culture was negative.16PubMed. Novel diagnosis of fungal endophthalmitis by broad-range real-time PCR detection of fungal 28S ribosomal DNA These molecular tools are not yet universally available, but they represent a meaningful advance for difficult cases.
Treatment and Why Natamycin Came Out on Top
The first-line treatment for fungal keratitis caused by filamentous fungi is natamycin eye drops, an antifungal that has been available for decades. For years, clinicians wondered whether newer drugs, particularly voriconazole, might outperform it. Two major randomized trials provided an answer, and it was not the one many ophthalmologists expected.
An earlier trial comparing the two drugs in 120 patients found no statistically significant difference in visual acuity or ulcer size at three months, though a post hoc subgroup analysis hinted at a possible advantage for voriconazole in patients with moderate baseline vision loss.17PubMed Central. Comparison of Natamycin and Voriconazole for the Treatment of Fungal Keratitis The larger follow-up trial, the Mycotic Ulcer Treatment Trial, settled the debate more firmly. Patients treated with natamycin had significantly better visual acuity at three months compared to those receiving voriconazole. Natamycin-treated patients were also less than half as likely to suffer corneal perforation or need emergency corneal transplant surgery. The advantage was especially dramatic in Fusarium infections, where voriconazole-treated patients were far more likely to experience perforation.18JAMA Ophthalmology. The Mycotic Ulcer Treatment Trial: A Randomized Trial Comparing Natamycin vs Voriconazole
This matters practically because voriconazole is more expensive and had been increasingly used off-label with the assumption that it would prove superior. For Fusarium keratitis in particular, the evidence now strongly favors natamycin. For infections caused by other filamentous fungi, the two drugs appeared roughly equivalent, so voriconazole retains a role in certain cases.
When infection penetrates deeper into the eye, causing endophthalmitis, treatment escalates. Systemic antifungal drugs are combined with direct injections of antifungal agents into the eye’s vitreous cavity. Intravitreal voriconazole and amphotericin B are both used for this purpose, with voriconazole showing favorable anatomical and clinical outcomes in a systematic review, though more safety data are still needed.19PubMed. The Effectiveness and Safety of Intravitreal Injections of Voriconazole in the Treatment of Fungal Endophthalmitis: A Systematic Review20Clinical Infectious Diseases. Treatment of Endogenous Fungal Endophthalmitis: Focus on New Antifungal Agents Surgical vitrectomy, removing the infected gel inside the eye, is sometimes necessary alongside medication.21PubMed Central. Fungal Endophthalmitis: A Comprehensive Review
When Surgery Becomes Necessary
If medications fail to control the infection and the cornea is at risk of perforation or has already perforated, a therapeutic corneal transplant becomes the last resort. This is not the elective procedure that might come to mind when people think of corneal transplants. It is emergency surgery to save the eye. Unfortunately, outcomes in this setting are worse than for routine transplants. In one series of patients who had transplants for drug-resistant fungal keratitis, nearly half experienced recurrence of the fungal infection afterward, and the graft rejection rate was about 18%. Despite those numbers, the procedure succeeded in preserving some vision and saving the eye in the majority of cases, making it a worthwhile intervention when all other options have been exhausted.22PubMed. Therapeutic Corneal Transplant for Fungal Keratitis Refractory to Medical Therapy
Another approach that has generated interest is corneal cross-linking, a procedure that uses ultraviolet light and riboflavin (vitamin B2) to stiffen the cornea. It has established applications in treating keratoconus, and researchers hoped it might also kill fungi and strengthen a weakened cornea during infection. Early reports were cautiously positive for some refractory cases.23PubMed Central. Corneal Cross-linking as an Adjunct for The Management of Refractory Fungal Keratitis However, a randomized clinical trial evaluating cross-linking as an add-on to standard antifungal therapy found no benefit. Patients who received cross-linking actually had worse visual acuity at three months, averaging about three lines worse on the eye chart compared to those who did not get the procedure.24PubMed Central. Cross-Linking-Assisted Infection Reduction: A Randomized Clinical Trial Evaluating the Effect of Adjuvant Cross-Linking on Outcomes in Fungal Keratitis This is a useful reminder that promising early results do not always hold up in rigorous trials.
How the Body Fights Back and Why It Sometimes Makes Things Worse
When fungal spores land on a damaged cornea, the body mounts an immune response. Cells in the cornea recognize signature molecules on the fungal cell wall, including chitin and beta-glucan, and trigger an inflammatory cascade. This brings a flood of neutrophils and other white blood cells to the site of infection.25PubMed Central. Immune Mechanisms of Filamentous Fungal Keratitis In theory, that immune response should help clear the infection. In practice, it often does as much damage as the fungus itself.
The arriving inflammatory cells release enzymes that break down corneal tissue. Research in animal models has shown that the amount of tissue-degrading enzyme activity in infected corneas correlates with the density of inflammatory cells rather than with the fungal burden alone.26PubMed. Enzymatic, clinical and histologic evaluation of corneal tissues in experimental fungal keratitis in rabbits This means that even as the immune system works to eliminate the invader, it can dissolve the very tissue it is trying to protect, contributing to corneal scarring and thinning. It is one reason why aggressive anti-inflammatory management, carefully balanced with antifungal therapy, is sometimes considered in severe cases, though this balance is difficult because suppressing the immune response too much lets the fungus gain ground.
Fungal Eye Infections in Children
Pediatric fungal keratitis is less common than the adult form but carries particular challenges. Children are less able to describe their symptoms clearly, which can delay diagnosis. In a 24-year study of pediatric cases, dense corneal infiltrates were seen in all patients, and feathery margins were present in about 70% of them. Hypopyon (pus in the front chamber of the eye) was uncommon in children compared to what is typically seen in adults.27PubMed Central. Pediatric Fungal Keratitis: Predisposing Factors, Clinical Features, and Outcomes During a 24-Year Study
Treatment outcomes in children can be sobering. In one series of 48 pediatric eyes, only about 17% were successfully treated with medications alone. Roughly two-thirds ultimately required corneal transplant surgery, and one eye had to be removed entirely.28Infection and Drug Resistance. Clinical Characteristics and Treatment Outcomes of Pediatric Fungal Keratitis That high surgical rate reflects both the aggressive nature of certain fungal infections and the practical difficulty of keeping a child compliant with hourly antifungal eye drops, which is the standard treatment regimen for severe cases. Early and aggressive treatment is considered essential in pediatric patients, including surgical removal of infected tissue when the infection does not respond quickly to medication.29Archives of Pediatric Infectious Diseases. Management of Fungal Keratitis in Pediatric Patients
Quality of Life and the Financial Toll
People who survive a fungal eye infection often face lasting vision impairment. Quality-of-life studies from the Mycotic Ulcer Treatment Trial showed that while most participants recovered good mobility and daily activity function at three months, self-reported visual function scores remained notably lower than other quality-of-life measures. Among patients with Fusarium keratitis, those treated with natamycin scored an average of about 8 points higher on an Indian visual function questionnaire than those treated with voriconazole, reinforcing the clinical trial findings about natamycin’s superiority in practical terms that matter to patients.30JAMA Ophthalmology. Vision-Related Quality-of-Life Outcomes in the Mycotic Ulcer Treatment Trial I: A Randomized Clinical Trial Reassuringly, another trial found that all patients reported improved quality of life three months after starting treatment compared to their baseline during the acute infection, suggesting that even when outcomes are imperfect, treatment makes a meaningful difference.31Journal of EuCornea. Vision-Related Quality of Life Outcomes in Patients Treated for Filamentous Fungal Keratitis in the CLAIR Trial
The financial burden is also significantly higher than for bacterial keratitis. A comparative cost analysis found that patients with fungal keratitis spent substantially more on medication than those with bacterial infections, whether or not they eventually needed surgery. The prolonged treatment course and higher price of antifungal drugs are the main drivers.32PubMed Central. Comparative study on costs incurred for treatment of patients with bacterial and fungal keratitis – A retrospective analysis In resource-limited settings where fungal keratitis is most common, these costs can be devastating for farming families already earning marginal incomes.
Growing Resistance and a Limited Drug Arsenal
Unlike the bacterial world, where dozens of antibiotic classes exist, the number of antifungal drug classes available for any human fungal infection is small. For eye infections specifically, the practical options are even narrower, because many systemic antifungals penetrate poorly into ocular tissue. This makes the emergence of antifungal resistance particularly worrying. Resistance patterns are rising in both immunocompromised and otherwise healthy populations, and the drug development pipeline for antifungals is far thinner than for antibiotics.33Future Microbiology. Emerging antifungal resistance: an updated review on current scenario, pathogens involved and tackling strategies A complicating factor is cross-resistance between agricultural fungicides used on crops and the antifungal drugs used in medicine: the same chemical classes appear in both settings, meaning heavy fungicide use in farming can breed resistant strains that then infect humans. For agricultural workers who are already the most exposed population, this creates a troubling feedback loop that receives far less public attention than antibiotic resistance.